Document Type

Article

Date

2016

Comments

The Scope showcases student-produced news articles about research and researchers at VCU.

Date of Submission

November 2016

Abstract

VCU researchers are experimenting with a new drug that targets the chaperone proteins that protect cancer cells. The drug AR-12 has the potential to fight off not only cancer but also Ebola, Zika and the human immunodeficiency virus, as well as bacterial infections.

Rights

© The Author(s)

Is Part Of

The Scope

Share

COinS